Oncology-Focused Arcus Ventures Raising Fund II

Cancer therapy investor Arcus Ventures has raised $36 million toward a planned third fund, according to a securities filing.

ByJoanna Glasner

12 March 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers North America US Briefs